ARTICLE | Clinical News
Adeza regulatory update
April 10, 1995 7:00 AM UTC
The FDA's Clinical Chemistry and Toxicology Advisory Committee recommended marketing approval of Adeza's diagnostic test for fetal fibronectin (fFN) that aids in detecting impending preterm delivery. ...